论文部分内容阅读
近４０年来肾实质性急性肾功能衰竭（ＡＲＦ）的治疗仍未超出支持与肾脏替代疗法的范畴，虽其存活率有所提高，但病死率仍高达５０％。随着细胞生物学与分子生物学的迅速发展，对ＡＲＦ的发病机制有了更深入的认识，随之出现的一些防治措施对缩短ＡＲＦ病程、减少病死率、...
Renal parenchymal acute renal failure (ARF) has not surpassed the supportive and renal replacement therapies in the past 40 years. Although the survival rate has risen, the case fatality rate remains as high as 50%. With the rapid development of cell biology and molecular biology, there is a deeper understanding of the pathogenesis of ARF, followed by some prevention and treatment measures to shorten the course of ARF, reduce mortality, ...